Literature DB >> 11073178

Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison.

K A Meadows1, C Abrams, A Sandbaek.   

Abstract

AIMS: To adapt the Diabetes Health Profile (DHP-1) for use with English speaking patients with Type 2 diabetes mellitus and to evaluate the psychometric properties of the adapted measure in a UK and Danish sample of insulin, tablet and diet-treated patients with Type 2 diabetes.
METHODS: Following linguistic adaptation using the forward-backward translation procedure, the 32-item DHP-1 was sent to 650 and 800 consecutively selected UK and Danish patients with Type 2 diabetes. Construct validity was assessed using principal axis factoring. Factor stability was assessed across language groups using the coefficient of congruence. Reliability was evaluated using Cronbach's alpha and multi-trait analysis, including item convergent/discriminant validity. Subscale discriminant validity was assessed through known groups with one-way ANOVA and post hoc Scheffe tests for multiple comparisons.
RESULTS: Eighteen items (56.25%) were retained following initial item analysis. A three-factor solution accounting for 45.6% and 40.3% of the total explained variance was identified in the UK and Danish samples, respectively. Factors were interpreted as psychological distress (PD), barriers to activity (BA) and disinhibited eating (DE). Factor congruence between language groups ranged from 0.98 to 0.99 and Cronbach's alpha ranged between 0.70 and 0.88. Item scaling success for both language versions was 88.9%. BA scores discriminated between treatment groups in both language groups (F = 24.24, P < 0.001; F = 7.68, P < 0.001) and PD scores in the UK sample (F = 20.97, P < 0.001).
CONCLUSIONS: The DHP-18 developed for use with patients with Type 2 diabetes has been shown to have satisfactory internal reliability and validity and measurement equivalence across language groups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073178     DOI: 10.1046/j.1464-5491.2000.00322.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  27 in total

Review 1.  Measurement of health-related QOL in diabetes mellitus.

Authors:  Ken Watkins; Cathleen M Connell
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Outcome tools for diabetes-specific quality of life: Study performed in a private family practice clinic.

Authors:  Rajesh Nair; Paul Kachan
Journal:  Can Fam Physician       Date:  2017-06       Impact factor: 3.275

Review 3.  Patient-reported assessments in diabetes care: clinical and research applications.

Authors:  Soren E Skovlund
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

4.  Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France.

Authors:  Stephanie Boini; Marie-Line Erpelding; Anne Fagot-Campagna; Mounir Mesbah; Judith Chwalow; Alfred Penfornis; Vincent Coliche; Etienne Mollet; Keith Meadows; Serge Briançon
Journal:  Health Qual Life Outcomes       Date:  2010-11-02       Impact factor: 3.186

5.  Sensitivity of three widely used questionnaires for measuring psychological distress among patients with type 2 diabetes mellitus.

Authors:  L S M Tan; E Y H Khoo; C S Tan; K Griva; Amir Mohamed; Michelle New; Y S Lee; Jeannette Lee; E S Tai; Hwee-Lin Wee
Journal:  Qual Life Res       Date:  2014-06-28       Impact factor: 4.147

6.  Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study.

Authors:  Ester Yeoh; Soon Guan Tan; Ying Shan Lee; Hwee Huan Tan; Ying Yee Low; Su Chi Lim; Chee Fang Sum; Subramaniam Tavintharan; Hwee Lin Wee
Journal:  Int J Clin Pract       Date:  2021-05-21       Impact factor: 3.149

7.  Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.

Authors:  Stephan Matthaei; Matthew Reaney; Chantal Mathieu; Claes-Göran Ostenson; Thure Krarup; Bruno Guerci; Jacek Kiljanski; Helmut Petto; David Bruhn; Michael Theodorakis
Journal:  Diabetes Ther       Date:  2012-06-20       Impact factor: 2.945

8.  A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial.

Authors:  Peter Bower; Martin Cartwright; Shashivadan P Hirani; James Barlow; Jane Hendy; Martin Knapp; Catherine Henderson; Anne Rogers; Caroline Sanders; Martin Bardsley; Adam Steventon; Raymond Fitzpatrick; Helen Doll; Stanton Newman
Journal:  BMC Health Serv Res       Date:  2011-08-05       Impact factor: 2.655

9.  A mobile telehealth intervention for adults with insulin-requiring diabetes: early results of a mixed-methods randomized controlled trial.

Authors:  Justine Baron; Shashivadan Hirani; Stanton Newman
Journal:  JMIR Res Protoc       Date:  2015-02-26

10.  Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.

Authors:  Matthew Reaney; Chantal Mathieu; Claes-Göran Ostenson; Stephan Matthaei; Thure Krarup; Jacek Kiljański; Carole Salaun-Martin; Hélène Sapin; Michael Theodorakis; Bruno Guerci
Journal:  Health Qual Life Outcomes       Date:  2013-12-26       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.